TissueTech Raises $10M for Ophthalmology Product Development

Miami-based TissueTech, a product developer for ophthalmology, optometry, musculoskeletal and wound care, completed a $10 million round of growth equity financing, according to a Miami Herald Business report.

Advertisement

Ballast Point Ventures and River Cities Capital Funds participated. The funding will help TissueTech develop commercial efforts and further research for all divisions.

More Articles on Ophthalmology:
Dr. Derek Ohlstein Joins St. Lucie Eye Associates in Florida
Silver Oak Service Partners Sells Ownership Stake in Physicians Endoscopy
Dr. Brian Jenkins Joins Hamilton Eye Institute at the University of Tennessee

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.